Skip to main content

Should Cancer Patients Receive Apixaban to Prevent Venous Thromboembolism? An Analysis of the AVERT Trial: January 2020 Annals of Emergency Medicine Journal Club


AUTHORS

Stubblefield WB , Courtney DM , Self WH , . Annals of emergency medicine. ; 75(1). 116-118

ABSTRACT



Tags: